acetyl l carnitine deficiency in patients with major depressive disorder A review of current evidence for acetyl-l-carnitine the treatment of depression Carnitine: Genetic Variants Affecting Mitochondrial
Description
doi: 10.1007/s00702-017-1720-0
Treatment of human K562 erythroleukemia cells with tBHQ and human K-1034 RPE cells with SFN has been reported to induce TXN [340, 341], and the increase in TXN protects mice against light-induced retinal damage [341]
PMID 17640558
R., Tauhid M
